Shape Memory Polymer for Stent Applications - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Shape Memory Polymer for Stent Applications

Description:

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Dr. Al-Sheikhly Dr. Bigio Dr. Briber Dr. Bonenberger Dr. Ethridge Dr. Fourney Dr. Kofinas Dr. Phaneuf ... – PowerPoint PPT presentation

Number of Views:858
Avg rating:3.0/5.0
Slides: 33
Provided by: mseUmdEd
Category:

less

Transcript and Presenter's Notes

Title: Shape Memory Polymer for Stent Applications


1
Shape Memory Polymer for Stent Applications
  • Jeremy Cheng
  • Sara Clementson
  • Grant Hatcher
  • Hilary Lane
  • Ryan Mulholland
  • Swezin Than Tun
  • ENMA490 Capstone Final Report
  • May 13th, 2009

2
Acknowledgments
  • Dr. Al-Sheikhly
  • Dr. Bigio
  • Dr. Briber
  • Dr. Bonenberger
  • Dr. Ethridge
  • Dr. Fourney
  • Dr. Kofinas
  • Dr. Phaneuf
  • Dr. Seog
  • Mr. John Abrahams
  • Mr. Michael Kasser
  • Mr. Tom Loughran
  • Mr. Xin Zhang

3
Outline
  • Background
  • Motivation
  • Intellectual merit impact
  • Technical approach
  • Fabrication
  • Testing
  • Simulations
  • Problems Encountered
  • Schedule
  • Future Work
  • Conclusions
  • References

4
Background
  • Stents reduce restenosis rates to 10-40
    following angioplasty
  • Desirable stent properties include
  • High radial strength
  • Good compliance matching with arterial walls
  • Biocompatible
  • Radio-opacity for visualization during X-ray,
    MRI, etc.
  • Contain drugs and/or genes for additional therapy

Stoeckel D, Bonsignore C, Duda S. A survey of
stent designs. Min Invas Ther Allied Technol
200211137-147.
5
Background (contd)
  • Shape memory polymers are based upon different
    conformations of polymer chains at different
    temperatures
  • Because shape memory effect is not due to a phase
    change, strains up to 400 are recoverable

Ratna et al. Recent advances in shape memory
polymers and composites. J Mat Sci 43 (2008) 254.
http//my.clevelandclinic.org/PublishingImages/hea
rt/stent_smart.jpg
6
Motivation
  • All stents currently approved for use by FDA are
    metallic
  • Disadvantages
  • Rapid expansion rates
  • Compliance mismatching
  • High manufacturing costs
  • Limited areas available for drug loading
  • Aim is to improve upon current stent technology
    through the use of a reinforced shape memory
    polymer with unique advantages

7
Intellectual merit impact
  • We hoped to gain an increased understanding of
    the strengthening mechanisms within a shape
    memory polymer
  • A reinforced shape memory polymer stent may be a
    safer and more biomedically friendly device
  • Stronger shape memory polymers will have
    applications in many fields, not just stents

8
Technical Approach
  • Reinforced SMP stent designed through
  • Fabrication of prototype reinforced SMP material
  • Mechanical testing of prototype material
  • Computer simulations of reinforced SMP stent
    response

9
Fabrication
  • Materials
  • Monomer tert-butylacrylate (tBA)
  • Crosslinker Poly(ethylene glycol)n
    dimethacrylate (PEGDMA)
  • Photoinitiator 2,2-Dimethoxy-2-phenylacetophenone
    (DMPA)
  • Reinforcement Montmorillonite clay platelets
    (Cloisite)
  • Samples made with 0, 0.5, 1, 2, 3
    reinforcement (by weight) at both 20 40
    crosslinking

10
Fabrication (contd)
  • tBA PEGDMA distilled with hydroquinone/methyl-es
    ter remover
  • tBA, PEGDMA, DMPA (0.1 wt), Cloisite mixed
    and injected into mold made of 1/16 viton gasket
    between two glass slides coated with Rain-X as a
    releasing agent

11
Fabrication (contd)
  • UV broad-spectrum light used in
    photopolymerization
  • Post-bake performed for 3hrs at 70C
  • Cost
  • Group spent 910.63 in researching
  • Materials 0.23/stent, total cost 3.05/stent

12
Testing
  • Tg determined using DSC
  • Only non-reinforced samples had obvious
    transition
  • 20 - 38C, 40 - 27C

20 40 non-reinforced samples
40 cross-linked samples
13
Testing (contd)
  • Compressive modulus calculated from tensile
    flexural tests using method of Mujika et al
  • Flexural modulus determined using TMA

14
Testing (contd)
15
Testing (contd)
  • Tensile modulus determined using tensile tester

Tensile test specimen
Tensile test apparatus furnace
16
Testing (contd)
  • Tensile modulus at body temperature

17
Testing (contd)
  • Compressive modulus calculation results
  • Direct measurements
    were also performed

18
Simulations
  • Two simulation categories
  • Reinforced SMP modulus determination
  • Buckling analysis
  • Stent designed as non-perforated cylinder
  • Modulus determination simulated using small block
    of SMP material

19
(No Transcript)
20
Simulations (contd)
  • Buckling analysis based on constant, uniform
    pressure on exterior of stent wall
  • Max pressure from Agrawal et al
  • 300mmHg (40KPa) differential pressure across
    stent
  • Use 80KPa for a safety factor of 2
  • Analyze for wall thickness when collapse occurs
  • Buckling theory

Timoshenko SA, Gere JM. Theory of elastic
stability. McGraw Hill, New York, New York 1961.
21
(No Transcript)
22
Problems Encountered
  • Unfamiliarity with bioengineering issues
  • ANSYS
  • Buckling
  • Fabrication
  • Bubbles, high wt samples
  • Tensile testing at body temperature
  • Oven, heat gradients
  • Communication between committees
  • Underestimated time for many processes

23
Initial Schedule
24
Final Schedule
25
Future Work
  • Biocompatibility testing
  • Cytotoxicity, thrombosis, platelet adhesion
  • Further environmental tests
  • Creep, erosion, wet strength
  • More detailed simulations
  • Uneven plaque distribution, non-cylindrical
    arteries
  • Shape memory effect testing
  • Strain recovery rates recovery times
  • Collapse press tests
  • Drug gene loading investigations
  • Sterilization techniques
  • Clinical trials

26
Conclusions
  • Testing revealed much lower than expected moduli
    for the reinforced SMP material at body
    temperature due to its lower than expected Tg
  • Must control Tg with two cross-linkers maintain
    above body temp
  • The low modulus of the prototype material
    resulted in a necessary stent wall thickness of
    480µm, about twice as large as is practical
  • 480µm wall thickness reduces flow rate to 58
    original flow rate
  • Simulations as performed were sufficient to show
    general trends in the behavior of the material
    but accuracy could be improved with more advanced
    version of software
  • Difficulties due to unfamiliarity with software

27
References
  • Yakacki CM, Shandas R, Lanning C, Rech B,
    Eckstein A, Gall K. Unconstrained recovery
    characterization of shape-memory polymer networks
    for cardiovascular applications. Biomaterials
    2007282255-2263.
  • Stoeckel D, Bonsignore C, Duda S. A survey of
    stent designs. Min Invas Ther Allied Technol
    200211137-147.
  • Timoshenko SA, Gere JM. Theory of elastic
    stability. McGraw Hill, New York, New York 1961.
  • Agrawal CM, Haas KF, Leopold DA, Clark HG.
    Evaluation of poly(l-lactic acid) as a material
    for intravascular polymeric stents. Biomaterials
    199213176-182.

28
Questions?
29
Supplement
PEGDMA
DMPA
tBA
Images from www.sigmaaldrich.com
30
Supplement
Tensile test at body temperature
Tensile test at room temperature
31
Supplement
Displacement in x-direction
Displacement in y-direction
Displacement in z-direction
32
Supplement
Typical failed buckling analysis resulting
displacement
Write a Comment
User Comments (0)
About PowerShow.com